Skip to content
Open access

Structural optimization of novel 1,3,4-oxadiazole-based antibacterial compounds for improved stability.

Oct 2026 · European journal of medicinal chemistry · Vol 321 Pt 2, pp. 119384 · 0 citations · 25 references
Medicine

TL;DR

The design and evaluation of analogues aimed at improving metabolic stability while defining the structural features required for antibacterial activity are described and key insights that may aid in identifying the compound's molecular target are provided.

Abstract

A 1,3,4-oxadiazole-based compound named 1771 and its derivatives have been reported to exhibit antibacterial activity against Gram-positive bacteria, with activity extending to Gram-negative pathogens upon disruption of the outer membrane permeability barrier and/or efflux pump systems. However, the precise mode of action of these compounds remains unknown, and their utility is limited by low metabolic stability. Here, we describe the design and evaluation of analogues aimed at improving metabolic stability while defining the structural features required for antibacterial activity. Structure activity relationship analysis identified the secondary amide and the phenyl group as essential for antibacterial activity. Introduction of a para-pentafluorosulfanyl (SF5) substituent yielded compound 9b, which showed improved antibacterial potency and microsomal stability when compared to 1771. Although 9b remained suboptimal in microsomal stability, it provided the best overall balance of antibacterial activity and metabolic profile. Overall these results define key structural requirements for activity and provide a foundation for further optimization of this oxadiazole-based antibacterial scaffold, while providing key insights that may aid in identifying the compound's molecular target.

Read PDF

Similar papers

Open access Sep 2026

Synthesis, molecular docking and biological activity assessment of novel 1,3,4-oxadiazole derivatives as broad-spectrum antifungal candidates

The presence of fungistatic properties and potential resistance issues associated with current azole drugs have created a growing demand for discovering novel antifungal agents without these negative attributes. This study introduces the synthesis of a unique series of 4-(5-(benzylthio)-1,3,4-oxadiazol-2-yl) phenol der...

Mohammad Shafiei, Sara Masoudinia, Mahfam Moradi et al. · 0 citations
Sep 2026

Bis-Triazole-Containing Heterocycles: Synthesis, Pharmacokinetic Prediction, Molecular Modeling, and Antimicrobial Activity Evaluation

The synthesis and evaluation of novel bis-triazole derivatives, designed to evaluate their antimicrobial activity against clinically relevant pathogens and to establish structure-activity relationships for future optimization, provide a basis for further optimization of triazole-based antimicrobial agents.

Ahmed M. Abobakr, Rasha A. Nabil, H. H. Temirek et al. · 0 citations
Review Open access Oct 2026

1,3,4-Oxadiazole–sulfonamide hybrids: recent advances in biological activities, structure–activity relationships, and therapeutic applications

The available evidence demonstrates the remarkable therapeutic versatility of 1,3,4-oxadiazole–sulfonamide hybrids and supports their continued exploration as promising scaffolds for future drug discovery and development.

Alshaimaa Hosney, Elshimaa M. N. Abdelhafez, Mamdouh F. A. Mohamed · 0 citations
Open access Oct 2026

Synthesis and biological evaluation of 1,2,3-triazolyl-sulfonyl-indole hybrids as potent antibacterial and immunomodulatory agents.

Findings designate 6i as a prospective candidate exhibiting significant antibacterial, antibiofilm, and host-directed immunomodulatory activities for the treatment of multidrug-resistant bacterial illnesses for the treatment of multidrug-resistant bacterial illnesses.

Bandi Muralikrishna, N. Sateesh, Rambabu Palabindela et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.